Background COVID-19 is characterised by respiratory symptoms, which deteriorate into
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a third of …

Baricitinib is an oral Janus kinase ( JAK )1/ JAK 2 inhibitor approved for the treatment of
rheumatoid arthritis ( RA ) that was independently predicted, using artificial intelligence ( AI ) …

Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is linked to KS, primary effusion
lymphomas (PEL), and a subset of multicentric Castleman's disease (MCD). Transcript mapping …

Castleman's disease is a rare B cell lymphoproliferative disorder related to excess interleukin-6
(IL-6)-like activity. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8), which …

SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective
treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses …

Leishmaniasis is a rarely reported disease among transplant recipients; however, the number
of published cases has quadrupled since the beginning of the 1990s. Most cases have …

Background Tocilizumab, a humanized monoclonal antibody, targets IL-6 receptors blocking
downstream pro-inflammatory effects of IL-6. In preliminary reports it was suggested to be …

Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their
incidence is increasing because of the growing complexity of patients. Five species of …

Background Physicians treating patients with coronavirus disease 2019 (COVID-19) increasingly
believe that the hyperinflammatory acute stage of COVID-19 results in a cytokine storm. …

Background. To overcome some of the limitations of conventional microbiologic techniques,
polymerase chain reaction (PCR)-based assays are proposed as useful tools for the …